IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Knoll Capital Management, LLC

Q1 2020 Holdings

Filed 2020-05-15 | 18 holdings | $4.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Anavex Life Sciences Corp(AVXL)COM NEW032797300$2.3M724,20550.8%
Aldeyra Therapeutics Inc(ALDX)COM01438T106$1.4M569,40531.3%
Corteva Inc(CTVA)COM22052L104$705.0K30,00015.7%
Biohaven Pharmactl Hldg Co L(BHVN)COMG11196105$29.2K857,4940.6%
Corbus Pharmaceuticals Hldgs(CRBPEUR)COM21833P103$26.4K5,045,8700.6%
Applied Therapeutics Inc(APLT)COM03828A101$21.0K642,0710.5%
Abeona Therapeutics Inc(ABEO1EUR)COM00289Y107$6.0K2,859,7670.1%
Blackstone Group LP(BXUSD)COM UNIT LTD09253U108$3.6K80,0000.1%
Entera Bio Ltd(ENTX)SHSM40527109$3.3K1,741,3630.1%
Eiger Biopharmaceuticals Inc(CLDNEUR)COM28249U105$3.2K475,2380.1%
Centurylink Inc(CTLEUR)COM156700106$2.1K220,0000.0%
Exicure Inc(XCUR)COM30205M101$1.9K1,277,7770.0%
Molecular TemplatesCOM608550109$1.5K113,9050.0%
Soligenix Inc.COM834223307$1.3K787,8300.0%
Dow Inc(DOW)COM260557103$87730,0000.0%
Catasys IncCOM PAR149049504$65543,0340.0%
Dupont de Nemours Inc(DD)COM26614N102$51215,0000.0%
BioXCel Therapeutics Inc(BTAIEUR)COM09075P105$44720,0000.0%